CAR-T Cell Therapy market Research Report by 2022, Forecast till 2035

  • CAR-T cell therapies have been shown to enable complete disease remission, omitting the need for any further treatment. Several studies have proven the efficacy of these therapy candidates.







    Driven by the ongoing pace of innovation and sufficient financial support from investors, the CAR-T cell therapy market is anticipated to witness substantial growth in the foreseen future







    The financial opportunity within the CAR-T cell therapy market has been analyzed across the following segments:




    • Target indication(s)
    • Non-Hodgkin's Lymphoma
    • multiple myeloma
    • Acute Lymphoblastic Leukemia
    • Chronic Lymphocytic Leukemia
    • Hodgkin's lymphoma
    • Acute myeloid leukemia
    • Ovarian Cancer
    • Generalized myasthenia gravis (MG)
    • Renal cell carcinoma
    • target antigen
    • CD19
    • BCMA
    • CD19/22
    • Others
    • Key Geographical Regions
    • NorthAmerica
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and North Africa
    • rest of the world


































    The Global CAR-T Cell Therapy Market (4 th Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:

    • Autolus
    • bluebird bio
    • Bristol Myers Squibb
    • Carsgene Therapeutics
    • Cellectis
    • Cellular Biomedicine Group
    • Gilead Sciences
    • Innovative Cellular Therapeutics
    • Kur Therapeutics
    • Noile Immune Biotech
    • Novartis
    • Shanghai GeneChem
    • Sinobioway Cell Therapy
    • Takara Bio
    • Wellington Zhaotai Therapies




    Table of Contents







    1. Preface




    2. Executive summary




    3. Introduction




    4. CAR-T Cell Therapies: Market Landscape




    5. Key Insights




    6. Clinical Trial ANALYSIS




    7. Key Opinion Leaders




    8. CAR-T Cell Therapy Profiles




    9. Partnerships And Collaborations




    10. Funding And Investment Analysis




    11. Patent Analysis




    12. Case Study: Cell Therapy Manufacturing




    13. Cost Price Analysis




    14. Market Forecast and Opportunity Analysis




    15. Promotional Analysis




    16. Company Profiles




    17. Concluding Remarks




    18. Executive Insights




    19. Appendix 1: Tabulated Data




    20. Appendix 2: List of Companies and Organizations







    Get more details on the CAR-T Cell Therapy Market report https://www.rootsanalysis.com/…therapies-market/269.html







    You may also be interested in the following titles:







    You may also like to learn what our experts are sharing in Roots educational series:







    About Roots Analysis




    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.







    Contact:




    ben johnson




    +1 (415) 800 3415




    Ben.johnson@rootsanalysis.com

Letzte Aktivitäten

Jetzt mitmachen!

Sie haben noch kein Benutzerkonto auf unserer Seite? Registrieren Sie sich kostenlos und nehmen Sie an unserer Community teil!